Wordt geladen...
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
PURPOSE: Non-surgical treatments for cervical intraepithelial neoplasia 2/3 (CIN2/3) are needed as surgical treatments have been shown to double preterm delivery rate. The goal of this study was to demonstrate safety of a human papillomavirus (HPV) therapeutic vaccine called PepCan, which consists o...
Bewaard in:
| Gepubliceerd in: | Oncoimmunology |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4590015/ https://ncbi.nlm.nih.gov/pubmed/26451301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1031439 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|